Coronavirus COVID-19 FAQs
The RCSI Bahrain campus has reopened after implementing updated measures and changes according to the RCSI Bahrain Health and Safety Guidelines. This is done in compliance with COVID-19 guidelines issued by the Bahraini Government.
Please continue to refer to this page and the latest official advice and guidance from the Ministry of Health (MOH), Higher Education Council (HEC) and other government entities.
The Coronavirus disease referred to as (COVID-19) is a new strain of Coronavirus that was recently discovered in China.
It can be transmitted from person to person by:
- Direct contact
- Droplets from sneezing, coughing, or talking
The main clinical symptoms of the Coronavirus disease (COVID-19) are Cough, Fever, and Shortness of Breath.
Students with medical conditions such as asthma, diabetes, immunosuppressive drug therapy including systemic corticosteroid treatment, heart conditions, neurological disorders and morbid obesity are at higher risk for Covid 19 illness and complications. If you have any of the above conditions, or you consider yourself to be at higher risk due to a condition not identified above, you should inform the Student Health and Wellbeing Unit.
There are no vaccines that protect against COVID-19. However, the World Health Organisation (WHO) has undertaken the ‘Solidarity Trial’, which will test coronavirus treatment approaches across several countries and compare data to find which treatments may be most effective. Bahrain, along with other countries such as Argentina, Canada, France, Iran, Norway, South Africa, Spain, Switzerland, and Thailand are included in the trial. These clinical trials on medications have taken place, but it is still too early to know whether the medication will be effective or not.
Although there is no specific treatment for COVID-19, the President of the Supreme Council of Health Lt. General Dr. Shaikh Mohammed bin Abdullah Al Khalifa, Head of the National Taskforce to Combat Coronavirus COVID-19, has affirmed that the therapeutic protocol of the Kingdom of Bahrain which uses Hydroxychloroquine (HCQ) medication in treating COVID-19-infected cases has proven its effectiveness in alleviating the symptoms of the virus and reducing its complications. HCQ is used as a main cure for diseases like malaria, rheumatoid arthritis and lupus. It proved to be very effective in alleviating virus-related symptoms, mainly pneumonia, pain, and fever.
Precautions to take:
- Wash your hands regularly with soap or disinfect hands with sanitisers containing a minimum of 70% alcohol
- Cover your mouth and nose when coughing and sneezing
- Keep your distance (1.5m) and avoid direct contact with anyone showing symptoms of a respiratory illness such as coughing or sneezing
- Avoid mass gatherings
- Cook meat and eggs thoroughly
- Follow the Coronavirus disease (COVID-19) safety guidelines provided by the Ministry of Health (MOH) and of the World Health Organisation (WHO) at all times
Yes. If you are sharing your home with others, you should stay in a different room from other people or be separated as much as possible. Wear a surgical mask when you are in the same room as another person, and when seeking medical care. Use a separate bathroom, if available.
Make sure that you do not share a room with people who are at risk of severe disease, such as elderly people and those who have heart, lung or kidney conditions, and diabetes.
Visitors who do not have an essential need to be in the home should not visit while you are isolating.
Anyone who experiences symptoms of the Coronavirus (COVID-19) or may have been in contact with a person who has the Coronavirus (COVID-19) is advised to contact the Hotline (444).
The health and safety of our students remains our priority, therefore RCSI Bahrain has invested in increasing the level of general cleaning completed on campus.
Extra measures we have put in place are as follows (this list is not inclusive):
- An Isolation Room has been designated and prepared for any person who experiences any symptoms of COVID-19 while on-campus.
- We have arranged for frequently touched surfaces, such as door handles, light switches, handrails etc. to be cleaned at increased frequency
- Welfare facilities and communal areas will also be cleaned more frequently
- Each room, office, laboratory, tutorial room and communal area will be provided with cleaning materials to keep the environment hygienically clean and we are advised to regularly clean any personal items brought in from home
- In addition to the scheduled cleaning and disinfection that would be carried out by the soft services team, everyone will be expected to clean their own stations daily and more importantly to “clean as you go” when moving around on campus to maintain the hygiene standards needed to kill any virus particles
As part of our measures to ensure a safe return to campus, all students are required to take part in our mandatory online induction before returning to campus. The COVID-19 pandemic has led to many necessary changes in how we go about our day to day activities in the University and the training will familiarise you with the University’s procedures in preventing the spread of the virus.
If you have any queries or concerns, please do not hesitate to get in touch with us at email@example.com.
Passengers are advised to check with their airlines to confirm the status of their flights in advance.
Entry into Bahrain remains restricted to nationals, residents and visa holders. Please liaise with Student Services for visa renewal on firstname.lastname@example.org.
All arriving passengers will be routed through the airport as per their travel histories, countries of travel origin and any symptoms reported. They will then be taken to designated areas of the airport for mandatory clinical examinations, which takes a minimum of two hours after arrival. All passengers arriving in Bahrain will be tested for COVID-19.
Arriving passengers will be charged for the first COVID-19 test and the second COVID-19 test (at BD30 each) after the period of 10 days. To support the health and safety of our students, RCSI Bahrain will be reimbursing the expense of these two COVID-19 tests for students for the first trip to Bahrain. Please note that proofs of payment are to be provided to obtain reimbursement
The compulsory 10-day self-isolation has been lifted on 20 August for all passengers who test negative to the first COVID-19 test performed upon arrival in Bahrain. All passengers must sign a form stating that they will follow self-isolation regulations until their first test result is published, which usually takes 1-2 days. If the first COVID-19 test result issued is negative, passengers can resume their normal activities (no quarantine). For citizens and residents, a second COVID-19 test is compulsory on the 10th day of their arrival.
If a COVID-19 test result is positive, passengers/citizens/residents will be advised of further courses of action by the Ministry of Health (MoH) staff. Passengers will also be followed up with by the Ministry of Health and they must be wearing a tracking bracelet during the quarantine period.
- If you travelled outside Bahrain over the past month, please notify us by email and enrol with the Medical Examination Registration Service https://www.moh.gov.bh/444.
- If you are unwell in Bahrain with cough, fever, difficulty breathing, please stay at home, call 444 and follow instructions provided
For students, please liaise with your SARA coordinator or the Student Health and Wellbeing Centre.
For staff, please liaise with HR.
This situation is evolving, and staff and students should continue to regularly check the RCSI Bahrain FAQ page along with the following online resources:
For more information on how Bahrain is battling COVID-19 please download the following documents
RCSI Bahrain Contribution to COVID-19 Clinical Trials
RCSI Bahrain has been honourably nominated to support the COVID-19 clinical trials in Bahrain under the direction of Professor Stephen Atkin, Head of School of Postgraduate Research.
With the aim to enhance the treatment protocols for COVID-19 patients in Bahrain and beyond, RCSI Bahrain sponsored the National Convalescent Plasma Clinical Trial in COVID-19 patients, in collaboration with the Bahrain Defence Force Hospital (BDF) and the Ministry of Health. This initiative comes under the directives from the Supreme Council of Health (SCH) President and taskforce head, His Excellency Lieutenant General Dr Shaikh Mohammed bin Abdulla Al Khalifa.
The clinical trial, which is being conducted in three centres around Bahrain, entails taking antibody-rich plasma that has been given by subjects that have recovered from COVID-19 and injecting it into patients who are severely suffering from the disease. Patients who have contracted COVID-19 and require oxygen therapy will be randomised to either the plasma treatment with supporting care, or normal supporting care, both of which will include drug treatment against the virus.